Fourth-Quarter Fiscal 2016 Achievements
Compared with Fourth-Quarter Fiscal 2015
-
Bookings of $24.9 million, up 19.7%
-
Revenue of $23.8 million, up 7.7%
-
Non-GAAP Diluted EPS of $0.17, up 70.0%
-
GAAP Diluted EPS of $0.11, up 57.1%
Full Year Fiscal 2016 Achievements Compared
with Full Year Fiscal 2015
-
Record Bookings of $102.3 million, up 15.9%
-
Record Revenue of $94.7 million, up 7.1%
-
Non-GAAP Diluted EPS of $0.77, up 18.5%
-
GAAP Diluted EPS of $0.61, up 1.7%
WEST WARWICK, R.I.--(BUSINESS WIRE)--
Astro-Med, Inc., d/b/a AstroNova (NASDAQ: ALOT), a leading manufacturer
of data visualization technology products for the aerospace, specialty
printing and test and measurement markets, today reported financial
results for the fourth quarter and full year ended January 31, 2016.
For the fiscal 2016 fourth quarter ended January 31, 2016, the Company
reported net sales of $23.8 million, an increase of 7.7% from $22.1
million for the prior-year period. Lower foreign exchange rates
negatively impacted net sales by $0.5 million in the fourth quarter of
fiscal 2016. Fourth-quarter fiscal 2016 GAAP net income increased to
$0.8 million, or $0.11 per diluted share, from $0.5 million, or $0.07
per diluted share, in the fourth quarter of fiscal 2015.
AstroNova reported non-GAAP net income of $1.3 million for the fiscal
2016 fourth quarter, compared with $0.8 million for the year earlier
period. Non-GAAP earnings per diluted share, which excludes the items as
listed in the table below, increased to $0.17 for the fourth quarter of
fiscal 2016, compared with $0.10 in the fourth quarter of fiscal 2015.
“We capped a successful fiscal 2016 with our 14th consecutive
quarter of year-on-year revenue growth, supported by double-digit
percentage increases in orders and backlog,” said President and Chief
Executive Officer Greg Woods. “Domestic revenue grew 14.9% for the
quarter and accounted for 73.4% of total sales. International sales –
despite a challenging economic environment – were comparable with the
prior year's fourth quarter sales, aided by the addition of new dealers
in Asia and Latin America as part of our overseas expansion.
“We are executing against a strategy built on expanding our geographic
reach, growing our recurring revenue stream, generating free cash flow
and creating a culture of innovation and continuous improvement that
resonates across both manufacturing and product development,” Woods
said. “During the past two years we have made significant strides in
transforming the way we do business, implementing lean initiatives and a
rigorous product planning process that have empowered our employees and
benefited our customers. These ongoing efforts will continue to create
opportunities for margin expansion and improved cash flow.”
Gross profit for the fourth quarter of fiscal 2016 was $9.1 million, or
38.4% of net sales, compared with $8.6 million, or 39.0% of net sales,
for the year-earlier period.
For the 12 months ended January 31, 2016, AstroNova reported net sales
of $94.7 million, an increase of 7.1% over the prior fiscal year’s net
sales of $88.3 million. Lower foreign exchange rates negatively impacted
net sales for fiscal 2016 by approximately $3.0 million. GAAP net income
was $4.5 million, or $0.61 per diluted share, in fiscal 2016, compared
with $4.7 million, or $0.60 per diluted share, in fiscal 2015.
The Company reported non-GAAP net income of $5.7 million for the full 12
months of fiscal 2016, an increase of 13.5% compared with non-GAAP net
income of $5.0 million in fiscal 2015. Non-GAAP earnings per diluted
share, which excludes the items listed in the table below, increased to
$0.77 for fiscal 2016, compared with $0.65 in fiscal 2015.
Cash and cash equivalents at January 31, 2016 were $20.4 million,
compared with cash and cash equivalents of $23.1 million at year-end
fiscal 2015. During fiscal 2016, the Company paid $7.4 million in cash
for the RITEC acquisition.
The Company generated cash from operating activities of $7.7 million and
free cash flow, defined as cash from operating activities less capital
expenditures for property, plant and equipment, of $4.7 million in
fiscal 2016, compared with cash from operating activities of $1.5
million and negative free cash flow of $0.8 million for fiscal 2015.
Business Highlights
QuickLabel Systems – Fourth Quarter Fiscal 2016
-
Net sales of $16.6 million, up 12.1% from $14.8 million for the fourth
quarter of fiscal 2015.
-
Segment operating profit of $1.7 million, or 10.2% of net sales,
compared with $0.9 million, or 5.8% of net sales, for the fourth
quarter of fiscal 2015.
Test & Measurement – Fourth Quarter Fiscal 2016
-
Net sales of $7.1 million in the fiscal 2016 fourth quarter, down 1.4%
from the fourth quarter of fiscal 2015, reflecting a shift in delivery
timing requirements for certain aircraft manufacturers to later
quarters for the Company’s aerospace printer product line.
-
Segment operating profit of $1.0 million, or 14.0% of net sales,
compared with $1.6 million, or 21.5% of net sales, for the same period
in fiscal 2015.
Board of Directors Declares Regular Quarterly Dividend
On February 19, 2016, the Directors of AstroNova declared a regular
quarterly cash dividend of $0.07 per share. The dividend, which
represents a cash dividend of $0.28 per share on an annualized basis, is
payable on March 30, 2016 to shareholders of record at the close of
business on March 11, 2016.
Business Outlook
“The investments we are making in new products, processes and
distribution position AstroNova for growth in fiscal 2017 and beyond,”
Woods said. “We will continue to support that growth through focused,
carefully planned strategies designed to advance our leadership in data
visualization technology.”
Fiscal 2016 Fourth-Quarter Conference Call
AstroNova will conduct an investor conference call at 9:00 a.m. ET
today. Investors can participate in the conference call by dialing
888-500-6970 (U.S. and Canada) or 719-785-1757 (International) with
passcode 702675.
Please join the call at least five minutes prior to the start time. You
can also hear a live webcast of the call by accessing the Investors
section of AstroNova’s website, www.astronovainc.com.
Supplemental slides are expected to be available this morning, prior to
the start of the call. The slides may be downloaded from the Investors
section of the AstroNova website.
Following the live broadcast, an audio webcast replay of the call will
be available at www.astronovainc.com.
A telephone replay of the conference call will be available for seven
days by dialing 888-203-1112 (U.S. and Canada) or 719-457-0820
(International) with passcode 1613433.
Use of Non-GAAP Financial Measures
In addition to financial measures prepared in accordance with generally
accepted accounting principles (GAAP), this press release contains the
following non-GAAP financial measures: non-GAAP net income, non-GAAP net
income per diluted share and free cash flow. The Company believes that
the inclusion of these non-GAAP financial measures in this press release
helps investors to gain a meaningful understanding of changes in the
Company's core operating results, and also can help investors who wish
to make comparisons between AstroNova and other companies on both a GAAP
and a non-GAAP basis. AstroNova’s management uses these non-GAAP
measures, in addition to GAAP financial measures, as the basis for
measuring its core operating performance and comparing such performance
to that of prior periods and to the performance of its competitors.
These measures are also used by the Company’s management to assist with
their financial and operating decision-making.
About AstroNova
Astro-Med, Inc., d/b/a AstroNova, a global
leader in data visualization technologies, designs, manufactures,
distributes and services a broad range of products that acquire, store,
analyze and present data in multiple formats. The Product Identification
segment offers a variety of hardware and software products and
associated consumables that allow customers to mark, track and enhance
the appearance of their products. Major brands include QuickLabel®, the
industry leader in onsite color label printing. The Test and Measurement
segment includes the T&M Product Group, which offers a suite of products
and services that acquire and record electronic signal data from local
and networked sensors. The Test and Measurement segment also includes a
line of Aerospace Products that are used in aircraft flight decks and
cabins to record, print and display data including flight plans,
navigation information, performance data, and maintenance information.
Astro-Med, Inc. is a member of the Russell Microcap® Index. Additional
information is available by visiting www.astronovainc.com.
Forward-Looking Statements
Information included in this news
release may contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Forward-looking
statements are not statements of historical fact, but rather reflect our
current expectations concerning future events and results. These
statements may include the use of the words “believes,” “expects,”
“intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,”
and similar expressions to identify forward-looking statements. Such
forward-looking statements, including those concerning growth through
acquisitions, involve risks, uncertainties and other factors, some of
which are beyond our control, which may cause our actual results,
performance or achievements to be materially different from those
expressed or implied by such forward-looking statements. These risks,
uncertainties, and factors include, but are not limited to, those
factors set forth in the Company’s Annual Report on Form 10-K for the
fiscal year ended January 31, 2015 and subsequent filings Astro-Med
makes with the Securities and Exchange Commission. The Company
undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise. The reader is cautioned not to unduly rely
on such forward-looking statements when evaluating the information
presented in this news release.
|
|
|
|
|
|
|
|
ASTRO-MED, INC.
|
Consolidated Statements of Income
|
In Thousands Except for Per Share Data
|
(Unaudited)
|
|
|
|
|
|
Three-Months Ended
|
|
|
Twelve-Months Ended
|
|
|
|
|
January 31, 2016
|
|
|
January 31, 2015
|
|
|
January 31, 2016
|
|
|
January 31, 2015
|
Net Sales
|
|
|
|
$23,761
|
|
|
$22,070
|
|
|
$94,658
|
|
|
$88,347
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit
|
|
|
|
9,130
|
|
|
8,601
|
|
|
38,158
|
|
|
36,977
|
|
|
|
|
38.4%
|
|
|
39.0%
|
|
|
40.3%
|
|
|
41.9%
|
Operating Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling
|
|
|
|
4,694
|
|
|
4,806
|
|
|
18,249
|
|
|
18,289
|
Research & Development
|
|
|
|
1,745
|
|
|
1,388
|
|
|
6,945
|
|
|
5,802
|
General & Administrative
|
|
|
|
1,898
|
|
|
1,614
|
|
|
7,030
|
|
|
5,655
|
|
|
|
|
8,337
|
|
|
7,808
|
|
|
32,224
|
|
|
29,746
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Income
|
|
|
|
793
|
|
|
793
|
|
|
5,934
|
|
|
7,231
|
|
|
|
|
3.3%
|
|
|
3.6%
|
|
|
6.3%
|
|
|
8.2%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Income (Expense), Net
|
|
|
|
387
|
|
|
(214)
|
|
|
975
|
|
|
(299)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Before Taxes
|
|
|
|
1,180
|
|
|
579
|
|
|
6,909
|
|
|
6,932
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Tax Provision
|
|
|
|
352
|
|
|
36
|
|
|
2,384
|
|
|
2,270
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income
|
|
|
|
$828
|
|
|
$543
|
|
|
$4,525
|
|
|
$4,662
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income per Common Share - Basic
|
|
|
|
$0.11
|
|
|
$0.07
|
|
|
$0.62
|
|
|
$0.61
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income per Common Share - Diluted
|
|
|
|
$0.11
|
|
|
$0.07
|
|
|
$0.61
|
|
|
$0.60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average Number of Common Shares - Basic
|
|
|
|
7,320
|
|
|
7,419
|
|
|
7,288
|
|
|
7,612
|
Weighted Average Number of Common Shares - Diluted
|
|
|
|
7,494
|
|
|
7,643
|
|
|
7,471
|
|
|
7,834
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends Declared Per Common Share
|
|
|
|
$0.07
|
|
|
$0.07
|
|
|
$0.28
|
|
|
$0.28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ASTRO-MED, INC.
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
|
For the years ended January 31
|
In Thousands
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2016
|
|
|
2015
|
Net Cash Provided by Operating Activities
|
|
|
|
$
|
7,727
|
|
|
|
$
|
1,491
|
|
|
|
|
|
|
|
|
|
Net Cash (Used in) Provided by Investing Activities
|
|
|
|
|
(3,542
|
)
|
|
|
|
5,745
|
|
|
|
|
|
|
|
|
|
Net Cash Used in Financing Activities
|
|
|
|
|
(1,596
|
)
|
|
|
|
(7,401
|
)
|
|
|
|
|
|
|
|
|
Effect of Exchange Rate Changes on Cash and Cash Equivalents
|
|
|
|
|
(504
|
)
|
|
|
|
(218
|
)
|
Net Increase (Decrease) in Cash and Cash Equivalents
|
|
|
|
|
2,085
|
|
|
|
|
(383
|
)
|
|
|
|
|
|
|
|
|
Cash and Cash Equivalents, Beginning of Year
|
|
|
|
|
7,958
|
|
|
|
|
8,341
|
|
Cash and Cash Equivalents, End of Year
|
|
|
|
$
|
10,043
|
|
|
|
$
|
7,958
|
|
|
|
|
|
|
|
|
|
Selected Consolidated Balance Sheet Data
|
In Thousands
|
(Unaudited)
|
|
|
|
|
|
As of
January 31, 2016
|
|
|
As of
January 31, 2015
|
Cash & Marketable Securities
|
|
|
|
$20,419
|
|
|
$23,132
|
Current Assets
|
|
|
|
$54,514
|
|
|
$59,289
|
Total Assets
|
|
|
|
$77,963
|
|
|
$74,330
|
Current Liabilities
|
|
|
|
$9,548
|
|
|
$9,569
|
Shareholders’ Equity
|
|
|
|
$67,373
|
|
|
$63,511
|
|
|
|
|
|
|
|
|
|
Reconciliation of Non-GAAP Adjustments
|
Income from Continuing Operations
|
Dollars In Thousands
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three-Months Ended
|
|
|
|
Twelve-Months Ended
|
|
|
|
|
January 31, 2016
|
|
|
January 31, 2015
|
|
|
|
January 31, 2016
|
|
|
January 31, 2015
|
GAAP based results:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income
|
|
|
|
$828
|
|
|
$543
|
|
|
|
$4,525
|
|
|
$4,662
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Add Back - Non-GAAP adjustments (net of taxes):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rebranding Initiatives
|
|
|
|
123
|
|
|
-
|
|
|
|
181
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RITEC Transaction/Transition Costs
|
|
|
|
259
|
|
|
-
|
|
|
|
663
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2016 Long-Term Incentive Plan Share-Based Compensation
|
|
|
|
96
|
|
|
-
|
|
|
|
357
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Write-down of TSA Inventory
|
|
|
|
-
|
|
|
-
|
|
|
|
-
|
|
|
168
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share Buyback Costs
|
|
|
|
-
|
|
|
68
|
|
|
|
-
|
|
|
68
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Write-down of Asset Held for Sale
|
|
|
|
-
|
|
|
147
|
|
|
|
-
|
|
|
147
|
Non-GAAP Net Income
|
|
|
|
$1,306
|
|
|
$758
|
|
|
|
$5,726
|
|
|
$5,045
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP based results:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EPS-Diluted
|
|
|
|
$0.11
|
|
|
$0.07
|
|
|
|
$0.61
|
|
|
$0.60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Add Back - Non-GAAP adjustments (net of taxes):
Rebranding Initiatives
|
|
|
|
0.02
|
|
|
-
|
|
|
|
0.02
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RITEC Transaction/Transition Costs
|
|
|
|
0.03
|
|
|
-
|
|
|
|
0.09
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2016 Long-Term Incentive Plan Share-Based Compensation
|
|
|
|
0.01
|
|
|
-
|
|
|
|
0.05
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Write-down of TSA Inventory
|
|
|
|
-
|
|
|
-
|
|
|
|
-
|
|
|
0.02
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share Buyback Costs
|
|
|
|
-
|
|
|
0.01
|
|
|
|
-
|
|
|
0.01
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Write-down of Asset Held for Sale
|
|
|
|
-
|
|
|
0.02
|
|
|
|
-
|
|
|
0.02
|
Non-GAAP EPS - Diluted
|
|
|
|
$0.17
|
|
|
$0.10
|
|
|
|
$0.77
|
|
|
$0.65
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Cash Provided by Operation Revenue to Free Cash
Flow
|
Dollars In Thousands
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
Twelve Months Ended
|
|
|
|
|
January 31, 2016
|
|
|
January 31, 2015
|
Net Cash Provided by Operating Activities
|
|
|
|
$7,727
|
|
|
$1,491
|
|
|
|
|
|
|
|
|
Expenditures for property, plant and equipment
|
|
|
|
(3,061)
|
|
|
(2,247)
|
Free Cash Flow
|
|
|
|
$4,666
|
|
|
$(756)
|

View source version on businesswire.com: http://www.businesswire.com/news/home/20160316005643/en/
Source: AstroNova